Lakis V, Chan N, Lyons R, Blackburn N, Nguyen T, Chang C
Cancers (Basel). 2025; 17(5).
PMID: 40075699
PMC: 11899704.
DOI: 10.3390/cancers17050852.
Jing S, Wang H, Lin P, Yuan J, Tang Z, Li H
NPJ Precis Oncol. 2025; 9(1):68.
PMID: 40069556
PMC: 11897387.
DOI: 10.1038/s41698-025-00857-1.
Ma L, Luan Y, Lu L
Cancer Med. 2025; 14(5):e70622.
PMID: 40062730
PMC: 11891933.
DOI: 10.1002/cam4.70622.
Mu X, Pan L, Wang X, Liu C, Li Y, Cai Y
Front Immunol. 2025; 16:1529569.
PMID: 40051627
PMC: 11882567.
DOI: 10.3389/fimmu.2025.1529569.
Hysi P, Hammond C
Invest Ophthalmol Vis Sci. 2025; 66(3):11.
PMID: 40042876
PMC: 11892535.
DOI: 10.1167/iovs.66.3.11.
STModule: identifying tissue modules to uncover spatial components and characteristics of transcriptomic landscapes.
Wang R, Qian Y, Guo X, Song F, Xiong Z, Cai S
Genome Med. 2025; 17(1):18.
PMID: 40033360
PMC: 11874447.
DOI: 10.1186/s13073-025-01441-9.
From morphology to single-cell molecules: high-resolution 3D histology in biomedicine.
Xu X, Su J, Zhu R, Li K, Zhao X, Fan J
Mol Cancer. 2025; 24(1):63.
PMID: 40033282
PMC: 11874780.
DOI: 10.1186/s12943-025-02240-x.
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes.
Zhang X, Lan R, Liu Y, Pillarisetty V, Li D, Zhao C
NPJ Precis Oncol. 2025; 9(1):58.
PMID: 40032924
PMC: 11876354.
DOI: 10.1038/s41698-025-00848-2.
Emerging clinical applications of single-cell RNA sequencing in oncology.
Boxer E, Feigin N, Tschernichovsky R, Darnell N, Greenwald A, Hoefflin R
Nat Rev Clin Oncol. 2025; .
PMID: 40021788
DOI: 10.1038/s41571-025-01003-3.
Spatial-Omics Methods and Applications.
Kulasinghe A, Berrell N, Donovan M, Nilges B
Methods Mol Biol. 2025; 2880:101-146.
PMID: 39900756
DOI: 10.1007/978-1-0716-4276-4_5.
Intratumor heterogeneity in KRAS signaling shapes treatment resistance.
Petrenko O, Kirillov V, DAmico S, Reich N
iScience. 2025; 28(2):111662.
PMID: 39898020
PMC: 11787500.
DOI: 10.1016/j.isci.2024.111662.
Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells.
Zhang Z, Xu H, He J, Hu Q, Liu Y, Xu Z
Cell Death Dis. 2025; 16(1):28.
PMID: 39827156
PMC: 11743205.
DOI: 10.1038/s41419-025-07330-8.
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review.
Cesano A, Augustin R, Barrea L, Bedognetti D, Bruno T, Carturan A
J Immunother Cancer. 2025; 13(1).
PMID: 39824527
PMC: 11749597.
DOI: 10.1136/jitc-2024-008876.
Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology.
Xu J, Pham M, Corbo V, Ponz-Sarvise M, Oni T, Ohlund D
Exp Mol Med. 2025; 57(1):50-58.
PMID: 39814914
PMC: 11799150.
DOI: 10.1038/s12276-024-01378-w.
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment.
Gadwa J, Yu J, Piper M, Knitz M, Darragh L, Olimpo N
J Immunother Cancer. 2025; 13(1).
PMID: 39773568
PMC: 11749720.
DOI: 10.1136/jitc-2024-010405.
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer.
Klein L, Tu M, Krebs N, Urbach L, Grimm D, Latif M
Nat Commun. 2025; 16(1):335.
PMID: 39762215
PMC: 11704331.
DOI: 10.1038/s41467-024-55330-7.
Dissecting tumor transcriptional heterogeneity from single-cell RNA-seq data by generalized binary covariance decomposition.
Liu Y, Carbonetto P, Willwerscheid J, Oakes S, Macleod K, Stephens M
Nat Genet. 2025; 57(1):263-273.
PMID: 39747597
DOI: 10.1038/s41588-024-01997-z.
Single-Nucleus and Spatial Transcriptome Profiling Delineates the Multicellular Ecosystem in Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.
Huang Y, Du Z, Lai Z, Wen D, Huang L, He M
Adv Sci (Weinh). 2024; 12(5):e2405749.
PMID: 39686623
PMC: 11791974.
DOI: 10.1002/advs.202405749.
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer.
Veghini L, Pasini D, Fang R, Delfino P, Filippini D, Neander C
Nat Commun. 2024; 15(1):10534.
PMID: 39627211
PMC: 11615044.
DOI: 10.1038/s41467-024-54975-8.
Multimodal single cell-resolved spatial proteomics reveal pancreatic tumor heterogeneity.
Xu Y, Wang X, Li Y, Mao Y, Su Y, Mao Y
Nat Commun. 2024; 15(1):10100.
PMID: 39572534
PMC: 11582669.
DOI: 10.1038/s41467-024-54438-0.